• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Hester Biosciences Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting

    12-11-2025 | 11:32 am

    Hester Biosciences' board approved Q2/H1 consolidated results. Q2 revenue was ₹70.97 Cr, while PAT jumped 71%. H1 revenue stood at ₹155.07 Cr, with PAT up 99%. Poultry grew, boosted by H9N2 vaccine approval, offsetting Animal Healthcare's delays. Focus on diversified growth.

    No comments yet. Be the first to comment!

    All announcements from Hester Biosciences Limited